CanSino Biologics, Inc. Class H (HK:6185)
:6185
Want to see HK:6185 full AI Analyst Report?
Comparison Results
Guangzhou Baiyunshan Pharmaceutical Holdings Company
HK$18.75
HK$38.86B
3.39
-7.86%
1 Buy
0 Hold
0 Sell
Moderate Buy
Livzon Pharmaceutical Group
HK$30.94
HK$29.40B
9.36
3.79%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Fosun Pharmaceutical (Group) Co
HK$19.63
HK$68.27B
13.21
24.54%
3 Buy
0 Hold
0 Sell
Strong Buy
China Resources Pharmaceutical Group Ltd.
HK$4.61
HK$30.16B
6.21
-4.95%
6 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$39.76
HK$203.76B
34.88
35.21%
10 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:6185
CanSino Biologics, Inc. Class H
28.26
-7.09
-20.06%
HK:0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
16.07
-0.66
-3.93%
HK:1513
Livzon Pharmaceutical Group
27.66
1.46
5.56%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
17.66
3.46
24.35%
HK:3320
China Resources Pharmaceutical Group Ltd.
4.80
-0.18
-3.67%
HK:3692
Hansoh Pharmaceutical Group Company Limited
33.60
8.58
34.29%